Dimitris Voliotis

Dimitris Voliotis

Directeur Technique/Scientifique/R&D chez RADIOPHARM THERANOSTICS LIMITED
63 ans
Health Technology
Consumer Services
Health Services

Profil

Dr. Dimitris Voliotis, MD, is a Chief Medical Officer at Radiopharm Theranostics Ltd. Dr. Voliotis was previously employed as a Senior Vice President-Clinical Development by Zentalis Pharmaceuticals, Inc., a Chief Development Officer by CureVac AG, a Global Head-Clinical Development Oncology by Eisai, Inc., and a Vice President & Head-Oncology Group by Bayer HealthCare AG.
He received his doctorate degree from Universität zu Köln.

Postes actifs de Dimitris Voliotis

SociétésPosteDébut
RADIOPHARM THERANOSTICS LIMITED Directeur Technique/Scientifique/R&D 20/08/2024

Anciens postes connus de Dimitris Voliotis

SociétésPosteFin
ZENTALIS PHARMACEUTICALS, INC. Corporate Officer/Principal 01/09/2023
Corporate Officer/Principal 01/02/2020
Corporate Officer/Principal 01/01/2019
Corporate Officer/Principal 01/09/2014
Voir l'expérience en détail de Dimitris Voliotis

Formation de Dimitris Voliotis

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

73

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

  1. Bourse
  2. Insiders
  3. Dimitris Voliotis
🔇